Qiaoling Li Selected Research

Qiaoling Li Research Topics

Disease

6	Infections 01/2021 - 01/2013
4	Neoplasms (Cancer) 01/2022 - 01/2012
3	Myocardial Infarction 07/2021 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2016
2	Inflammation (Inflammations) 02/2022 - 01/2020
2	Necrosis 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 07/2021 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 08/2020 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2020 - 01/2019
1	Left Ventricular Dysfunction 02/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Diabetes Mellitus 12/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Dyslipidemias (Dyslipidemia) 12/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Ischemic Stroke 08/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Atherosclerosis 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Hemorrhage 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Hyperplasia 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Neointima 01/2020
1	Infarction (Infarctions) 12/2019
1	Cognitive Dysfunction 10/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Cerebral Infarction 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2018
1	Carcinogenesis 02/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018
1	Uterine Cervical Dysplasia 02/2018
1	Neoplasm Metastasis (Metastasis) 04/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2016
3	Therapeutic UsesIBA 01/2022 - 09/2019
2	Serum AlbuminIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
2	florfenicolIBA 01/2021 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 12/2020 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 12/2020 - 01/2019
2	HMGB1 Protein (HMG1)IBA 08/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	2-hexyl-4-pentynoic acidIBA 01/2022
1	L 30 (L-30)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Kanamycin KinaseIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AminoglycosidesIBA 01/2021
1	CoagulaseIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2020
1	punicalaginIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	Complement Factor B (Factor B)IBA 08/2020
1	Oxygen (Dioxygen)IBA 08/2020
1	NF-kappa B (NF-kB)IBA 08/2020
1	Toll-Like Receptor 4IBA 08/2020
1	LipidsIBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	ColforsinIBA 01/2020
1	Gallic AcidIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Heme (Haem)IBA 01/2020
1	PCSK9 InhibitorsIBA 01/2020
1	IronIBA 01/2020
1	CholesterolIBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 10/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2019
1	Ubiquitin-Conjugating EnzymesIBA 06/2019
1	GlypicansIBA 06/2019
1	Polycomb Repressive Complex 1IBA 06/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Ellagic AcidIBA 01/2019
1	EnzymesIBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	luteolin-7-glucosideIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	CreatinineIBA 01/2019
1	Messenger RNA (mRNA)IBA 02/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2018
1	Histidine (L-Histidine)FDA Link 02/2018

Therapy/Procedure

4	Therapeutics 12/2020 - 09/2006
1	Percutaneous Coronary Intervention 01/2020
1	Intravenous Administration 04/2016